These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33098603)

  • 1. An assessment of poly (ADP-ribose) polymerase-1 role in normal and cancer cells.
    Kumar M; Jaiswal RK; Yadava PK; Singh RP
    Biofactors; 2020 Nov; 46(6):894-905. PubMed ID: 33098603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
    Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
    Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
    Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
    Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG Cells.
    Schacke M; Kumar J; Colwell N; Hermanson K; Folle GA; Nechaev S; Dhasarathy A; Lafon-Hughes L
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.
    Amé JC; Rolli V; Schreiber V; Niedergang C; Apiou F; Decker P; Muller S; Höger T; Ménissier-de Murcia J; de Murcia G
    J Biol Chem; 1999 Jun; 274(25):17860-8. PubMed ID: 10364231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PARP Way to Epigenetic Changes.
    Ummarino S; Hausman C; Di Ruscio A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
    Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
    Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival.
    Jubin T; Kadam A; Jariwala M; Bhatt S; Sutariya S; Gani AR; Gautam S; Begum R
    Cell Prolif; 2016 Aug; 49(4):421-37. PubMed ID: 27329285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
    Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
    DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
    Kauppinen TM; Swanson RA
    Neuroscience; 2007 Apr; 145(4):1267-72. PubMed ID: 17084037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications.
    Tao Z; Gao P; Liu HW
    J Am Chem Soc; 2009 Oct; 131(40):14258-60. PubMed ID: 19764761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated signals from the DNA repair enzymes PARP-1 and PARP-2 promotes B-cell development and function.
    Galindo-Campos MA; Bedora-Faure M; Farrés J; Lescale C; Moreno-Lama L; Martínez C; Martín-Caballero J; Ampurdanés C; Aparicio P; Dantzer F; Cerutti A; Deriano L; Yélamos J
    Cell Death Differ; 2019 Dec; 26(12):2667-2681. PubMed ID: 30996287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.